J
James N'Dow
Researcher at University of Aberdeen
Publications - 180
Citations - 7726
James N'Dow is an academic researcher from University of Aberdeen. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 41, co-authored 151 publications receiving 6030 citations. Previous affiliations of James N'Dow include Aberdeen Royal Infirmary & University of Coimbra.
Papers
More filters
Journal ArticleDOI
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
Matthias Oelke,Alexander Bachmann,Aurélien Descazeaud,Mark Emberton,Stavros Gravas,Martin C. Michel,James N'Dow,Jørgen Nordling,Jean J.M.C.H. de la Rosette +8 more
TL;DR: The 2013 version of the European Association of Urology guidelines on the treatment and follow-up of male lower urinary tract symptoms (LUTS) provides practical guidance for the management of men experiencing LUTS.
Journal ArticleDOI
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
Richard Sylvester,Willem Oosterlinck,Sten Holmäng,Matthew R. Sydes,Alison Birtle,Sigurdur Gudjonsson,Cosimo De Nunzio,Kikuo Okamura,Eero Kaasinen,Eduardo Solsona,Bedeir Ali-El-Dein,Can Ali Tatar,Brant A. Inman,James N'Dow,Jorg R. Oddens,Marek Babjuk +15 more
TL;DR: A single instillation of chemotherapy immediately after resection reduces the risk of recurrence in non-muscle-invasive bladder cancer; however, it should not be given to patients at high risk of Recurrence due to its lack of efficacy in this subgroup.
Journal ArticleDOI
Systematic review of oncological outcomes following surgical management of localised renal cancer.
Steven MacLennan,Mari Imamura,Marie Carmela M. Lapitan,Muhammad Imran Omar,Thomas B. Lam,Thomas B. Lam,Ana M. Hilvano-Cabungcal,Pamela Royle,Fiona Stewart,Graeme MacLennan,Sara MacLennan,Steven E. Canfield,Samuel McClinton,T.R. Leyshon Griffiths,Börje Ljungberg,James N'Dow,James N'Dow +16 more
TL;DR: The evidence base suggests localised RCCs are best managed by nephron-sparing surgery where technically feasible, however, the current evidence base has significant limitations due to studies of low methodological quality marked by high risks of bias.
Journal ArticleDOI
Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer.
Graham Mowatt,Shihua Zhu,Mary Kilonzo,Charles Boachie,Cynthia Fraser,T.R.L. Griffiths,James N'Dow,Ghulam Nabi,Jonathan Cook,Luke Vale +9 more
TL;DR: In this paper, an economic model was constructed to assess the cost-effectiveness of alternative diagnostic and follow-up strategies for the diagnosis and management of patients with bladder cancer using photodynamic diagnosis (PDD).
Journal ArticleDOI
Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial
Robert Pickard,Kathryn Starr,Graeme MacLennan,Thomas B Lam,Ruth Thomas,Jennifer Burr,Gladys McPherson,Alison McDonald,Kenneth Anson,James N'Dow,Neil Burgess,Terry Clark,Mary Kilonzo,Kate Gillies,Kirsty Shearer,Charles Boachie,Sarah Cameron,John Norrie,Samuel McClinton,Samuel McClinton +19 more
TL;DR: Tamsulosin 400 μg and nifedipine 30 mg are not effective at decreasing the need for further treatment to achieve stone clearance in 4 weeks for patients with expectantly managed ureteric colic.